Rationale for adopting a combination of monoparametric MRI with the prostate-specific antigen in detecting clinically significant prostate cancer: comparison with standard biparametric and multiparametric MRI
British Journal of Radiology · 2024
DOI: 10.1093/bjr/tqae134 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Seung Hyun Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Eunpyeong St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Research Foundation of Korea, NRF.
Abstract (Originalsprache)
Objectives
To compare prostate monoparametric MRI (monoMRI), which uses only diffusion-weighted imaging (DWI), with biparametric (bpMRI) and multiparametric MRI (mpMRI) in detecting clinically significant cancer (CSC) and to evaluate the effect of the combination of monoMRI results and prostate-specific antigen (PSA) level.
Methods
In this study, 193 patients (average age 70.5 years; average PSA 7.9 ng/mL) underwent prebiopsy MRI and subsequent prostate biopsy from January 2020 to February 2022. Two radiologists independently reviewed the 3 MRI protocols using the Prostate Imaging Reporting and Data System (PI-RADS). Interreader agreement was assessed using the intraclass correlation coefficient (ICC), and diagnostic performance was evaluated with receiver operating characteristic (ROC) curve analysis. The Youden index was used to determine the new cutoff value of PSA for detecting CSCs in patients with negative monoMRI results.
Results
CSC was confirmed in 109 patients (56.5%). The interreader agreement on monoMRI (ICC = 0.798) was comparable to that on bpMRI and mpMRI (ICC = 0.751 and 0.714, respectively). ROC curve analysis of the 3 protocols revealed no difference in detecting CSCs (P > 0.05). Applying a new PSA cutoff value (9.5 and 7.4 ng/mL, respectively) in monoMRI-negative patients improved the sensitivity of monoMRI from 89.9% to 96.3% for Reader 1, and from 95.4% to 99.1% for Reader 2.
Conclusions
MonoMRI based solely on DWI demonstrated similar diagnostic performance to bpMRI and mpMRI in detecting CSCs, and the combination of PSA level with monoMRI has the potential to effectively triage patients with a high likelihood of CSCs. Advances in knowledge Monoparametric MRI conducted only with diffusion-weighted imaging (DWI), may show comparable performance to biparametric and multiparametric MRI in detecting clinically significant prostate cancer. In patients with negative monoparametric MRI results, implementing a new PSA cutoff value to determine the need for a biopsy could decrease the number of missed prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Eunpyeong St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
ORCID-Profile: Moon Hyung Choi
Förderung
- National Research Foundation of Korea
- NRF
Zitieren
APA
Park, S. H., Choi, M. H., Lee, Y. J., & Jung, S. E. (2024). Rationale for adopting a combination of monoparametric MRI with the prostate-specific antigen in detecting clinically significant prostate cancer: comparison with standard biparametric and multiparametric MRI. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae134
Vancouver
Park SH, Choi MH, Lee YJ, Jung SE. Rationale for adopting a combination of monoparametric MRI with the prostate-specific antigen in detecting clinically significant prostate cancer: comparison with standard biparametric and multiparametric MRI. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae134
BibTeX
@article{Park2024,
author = {Park, Seung Hyun and Choi, Moon Hyung and Lee, Young Joon and Jung, Seung Eun},
title = {Rationale for adopting a combination of monoparametric MRI with the prostate-specific antigen in detecting clinically significant prostate cancer: comparison with standard biparametric and multiparametric MRI},
journal = {British Journal of Radiology},
year = {2024},
doi = {10.1093/bjr/tqae134}
}
EUVIMED